Apoplogic Pharmaceuticals LLC is categorized under Research and Development Laboratories in Aurora, CO and active since 2005.
Apoplogic Pharmaceuticals LLC was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Richard Duke at the company’s single location by writing to 12635 East Montview Boulevard, Aurora, Colorado CO 80045 or by phoning (720) 859-4073. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Apoplogic Pharmaceuticals LLC |
Contact Person: | Richard Duke |
Address: | 12635 East Montview Boulevard, Aurora, Colorado 80045 |
Phone Number: | (720) 859-4073 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Apoplogic Pharmaceuticals LLC was started in 2005 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Richard Duke for inquiries that concern Apoplogic Pharmaceuticals LLC by calling the company number (720) 859-4073, as your correspondence is most welcome. Additionally, the physical location of the single location of Apoplogic Pharmaceuticals LLC can be found at the coordinates 39.74756,-104.840619 as well as the street address 12635 East Montview Boulevard in Aurora, Colorado 80045.
For its online presence, you may visit Apoplogic Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.